Literature DB >> 3760147

Endocarditis with Moraxella-like M-6 after cardiac catheterization.

R E Perez.   

Abstract

A patient developed bacteremia with CDC group M-6, a Moraxella-like bacterium, after a complicated heart catheterization. He was treated with tobramycin and ampicillin. The aortic valve was later replaced and did not show any signs of infection. The slow growth of M-6 can delay diagnosis and give misleading antibiotic susceptibility results. Penicillin is not always active against this organism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3760147      PMCID: PMC268951          DOI: 10.1128/jcm.24.3.501-502.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  3 in total

Review 1.  Drug therapy. Serum bactericidal activity as a monitor of antibiotic therapy.

Authors:  J S Wolfson; M N Swartz
Journal:  N Engl J Med       Date:  1985-04-11       Impact factor: 91.245

2.  Endocarditis caused by M6.

Authors:  A E Simor; I E Salit
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

3.  Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young.

Authors:  S T Shulman; D P Amren; A L Bisno; A S Dajani; D T Durack; M A Gerber; E L Kaplan; H D Millard; W E Sanders; R H Schwartz
Journal:  Circulation       Date:  1984-12       Impact factor: 29.690

  3 in total
  8 in total

1.  Neisseria elongata endocarditis of a native aortic valve.

Authors:  Mohammed Samannodi; Sujit Vakkalanka; Andrew Zhao; Michael Hocko
Journal:  BMJ Case Rep       Date:  2016-02-25

2.  Neisseria elongata subsp. elongata, a case of human endocarditis complicated by pseudoaneurysm.

Authors:  T Nawaz; D J Hardy; W Bonnez
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes.

Authors:  Adriano A M Truffa; Christopher B Granger; Kyle R White; L Kristin Newby; Rajendra H Mehta; Judith S Hochman; Manesh R Patel; Karen S Pieper; Hussein R Al-Khalidi; Paul W Armstrong; Renato D Lopes
Journal:  JACC Cardiovasc Interv       Date:  2012-07       Impact factor: 11.195

4.  Association of an important Neisseria species, Neisseria elongata subsp. nitroreducens, with bacteremia, endocarditis, and osteomyelitis.

Authors:  J D Wong; J M Janda
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

5.  Neisseria elongata subsp. nitroreducens subsp. nov., formerly CDC group M-6, a gram-negative bacterium associated with endocarditis.

Authors:  P E Grant; D J Brenner; A G Steigerwalt; D G Hollis; R E Weaver
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

6.  Bioprosthetic valve endocarditis caused by Neisseria elongata subspecies nitroreducens.

Authors:  P Meuleman; K Erard; M C Herregods; W E Peetermans; J Verhaegen
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

7.  Infectious endocarditis with systemic septic embolization as a rare complication of cardiac catheterization.

Authors:  Sasanka Jayasuriya; Mohammad Reza Movahed
Journal:  Exp Clin Cardiol       Date:  2009

Review 8.  Endocarditis caused by Neisseria elongata subspecies nitroreducens: case report and literature review.

Authors:  L Struillou; F Raffi; J H Barrier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.